TolerRX Biotech Specialty Pharma

300 Technology Square, 3rd Floor

Cambridge, MA 02139 USA Phone Fax

Click for website

Research Sector Biotech Specialty Pharma

Summary Description Technologies that induce or remove immunological tolerance.

Management Douglas J. Ringler, V.M.D., Co-Founder, President & Chief Executive Officer; Herman Waldmann , Ph.D., FRCPath, MRCP, FRS, FMedSci, Co-Founder, Chairman, Scientific Advisory Board; Louis Vaickus, M.D., Chief Medical Officer; Thomas A. Shea, M.B.A., Chief Financial Officer

Click here for Financial Data Keywords: cancer, monoclonal antibodies, Diabetes, blood sugar, diabetic, metabolic, insulin, immune system, psoriatic arthritis, autoimmune disease

RELATED COMPANIES



0000-00-00-2501